InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Detheux Michel, Chairman & CEO. Insider active across 2 companies, notably iTeos Therapeutics, Inc.. In total, 20 filings have been logged. Split: 0 buy · 11 sells. Total volume traded: €2.3m. Activity tracked since 14 June 2021. The latest transaction was filed on 9 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Detheux Michel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
153,903 sharesCommon StockSEC:0000950170-25-112240:0
8,400 shares@ US$4.3050.0% of flowCommon StockSEC:0000950170-25-085047:0
8,400 shares@ US$4.3050.0% of flowCommon StockSEC:0000950170-25-083411:0
77,000 shares0Common StockSEC:0000950170-25-037515:0
30,000 shares0Common StockSEC:0000950170-23-068900:0
11,500 shares@ US$4.231.8% of flowCommon StockSEC:0001209191-22-024859:0
5,822 shares@ US$33.447.0% of flowCommon StockSEC:0001209191-22-020649:0
10,000 shares0Common StockSEC:0001209191-22-018667:0
13,956 shares@ US$34.3016.8% of flowCommon StockSEC:0001209191-22-012880:0
10,088 shares@ US$35.4512.5% of flowCommon StockSEC:0001209191-22-005118:0
9,111 shares@ US$4.301.4% of flowCommon StockSEC:0001209191-21-070996:0
16,263 shares@ US$12.457.1% of flowCommon StockSEC:0001209191-21-066884:0
81 shares@ US$28.000.1% of flowCommon StockSEC:0001209191-21-062843:0
196 shares@ US$28.00010.2% of flowCommon StockSEC:0001209191-21-061569:0
1,635 shares@ US$28.011.6% of flowCommon StockSEC:0001209191-21-061042:0
5,322 shares@ US$28.1595.1% of flowCommon StockSEC:0001209191-21-057850:0
8,684 shares@ US$28.2968.2% of flowCommon StockSEC:0001209191-21-054904:0
8,248 shares@ US$28.177.8% of flowCommon StockSEC:0001209191-21-054169:0
7,499 shares@ US$28.067.1% of flowCommon StockSEC:0001209191-21-053381:0
25,063 shares@ US$28.381923.3% of flowCommon StockSEC:0000899243-21-024238:0
20 of 20 declarations
About Detheux Michel
Detheux Michel is President and Chief Executive Officer and Chief Executive Officer at iTeos Therapeutics, Inc. Across the 20 filings recorded, the sampled filings cover the period from 2021-06-16 to 2025-08-29 and show sales totaling EUR 2,260,008, with no purchases indicated.
